Clinical Trial Update: Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia [NA]

View source ↗

Summary

A multicenter, open-label, randomized, haloperidol-controlled trial evaluating quetiapine (Seroquel) as monotherapy for agitation in patients with an acute epis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Peking University | Conditions: Schizophrenia | NA | Status: COMPLETED